The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease

Alzheimer’s disease (AD), with main clinical features of progressive impairment in cognitive and behavioral functions, is the most common degenerative disease of the central nervous system. Recent evidence showed that microRNAs (miRNAs) played important roles in the pathological progression of AD. In this article, we reviewed the promising role of miRNAs in both Aβ deposition and Tau phosphorylation, two key pathological characters in the pathological progression of AD, which might be helpful for the understanding of pathogenesis and the development of new strategies of clinical diagnosis and treatment of AD.

[1]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[2]  X. Bo,et al.  Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model , 2013, Front. Aging Neurosci..

[3]  M. Mobashir,et al.  Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease. , 2016, European journal of medicinal chemistry.

[4]  F. Slack,et al.  The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. , 2008, Developmental biology.

[5]  F. LaFerla,et al.  Upregulation of miR-181 decreases c-Fos and SIRT-1 in the hippocampus of 3xTg-AD mice. , 2014, Journal of Alzheimer's disease : JAD.

[6]  James B Leverenz,et al.  The biomarker and therapeutic potential of miRNA in Alzheimer's disease. , 2015, Neurodegenerative disease management.

[7]  S. Hébert,et al.  In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs , 2011, Journal of neurochemistry.

[8]  J. Su,et al.  MicroRNA-139 modulates Alzheimer's-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2. , 2017, Genetics and molecular research : GMR.

[9]  P. Reddy,et al.  Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? , 2016, Biochimica et biophysica acta.

[10]  Ying-chao Liu,et al.  MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2 , 2012, Brain Research.

[11]  H. Geekiyanage,et al.  MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid β, Novel Targets in Sporadic Alzheimer's Disease , 2011, The Journal of Neuroscience.

[12]  Tomaž Curk,et al.  Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. , 2011, Genome research.

[13]  L. Buée,et al.  MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy , 2011, Alzheimer's & Dementia.

[14]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[15]  M. Nalls,et al.  Evidence for natural antisense transcript-mediated inhibition of microRNA function , 2010, Genome Biology.

[16]  W. Lukiw,et al.  Regulation of Neurotropic Signaling by the Inducible, NF-kB-Sensitive miRNA-125b in Alzheimer's Disease (AD) and in Primary Human Neuronal-Glial (HNG) Cells , 2013, Molecular Neurobiology.

[17]  S. Pan,et al.  MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo. , 2015, Molecular medicine reports.

[18]  Li-xiang Xue,et al.  MicroRNA-135a and -200b, potential Biomarkers for Alzheimer׳s disease, regulate β secretase and amyloid precursor protein , 2014, Brain Research.

[19]  B. Ray,et al.  MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects* , 2013, The Journal of Biological Chemistry.

[20]  W. Lukiw,et al.  Pathogenic microRNAs Common to Brain and Retinal Degeneration; Recent Observations in Alzheimer’s Disease and Age-Related Macular Degeneration , 2015, Front. Neurol..

[21]  C. Wellington,et al.  High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease. , 2014, Cell metabolism.

[22]  Shunjiang Xu,et al.  Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice , 2016, Journal of the Neurological Sciences.

[23]  Michael A Lopez,et al.  Mechanical Stretch Up-regulates MicroRNA-26a and Induces Human Airway Smooth Muscle Hypertrophy by Suppressing Glycogen Synthase Kinase-3β* , 2010, The Journal of Biological Chemistry.

[24]  Luc Buée,et al.  Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. , 2010, Human molecular genetics.

[25]  M. Wolfe,et al.  Alternative polyadenylation and miR‐34 family members regulate tau expression , 2013, Journal of neurochemistry.

[26]  G. Schellenberg,et al.  Regulation of tau isoform expression and dementia. , 2005, Biochimica et biophysica acta.

[27]  Yan Kong,et al.  MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model. , 2014, Current Alzheimer research.

[28]  Israel Hernandez,et al.  The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule , 2009, The Journal of Neuroscience.

[29]  N. Bonini,et al.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration. , 2006, Molecular cell.

[30]  J. Malter,et al.  Rck/p54 interacts with APP mRNA as part of a multi-protein complex and enhances APP mRNA and protein expression in neuronal cell lines , 2009, Neurobiology of Aging.

[31]  P. Hof,et al.  Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus , 2010, Brain Research.

[32]  Leung-Wing Chu,et al.  Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders , 2011, International Psychogeriatrics.

[33]  G. Glinsky.  An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway , 2008, Cell cycle.

[34]  C. Barbato,et al.  A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons , 2014, Front. Cell. Neurosci..

[35]  Lianfeng Zhang,et al.  miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor , 2010, Brain Research.

[36]  I. Plante,et al.  MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1* , 2009, Journal of Biological Chemistry.

[37]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[38]  Jidong Zhang,et al.  MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4 , 2016, Front. Immunol..

[39]  Yanan Jiao,et al.  Osthole decreases beta amyloid levels through up-regulation of miR-107 in Alzheimer’s disease , 2016, Neuropharmacology.

[40]  E. Mufson,et al.  Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment , 2015, Front. Neurosci..

[41]  C. Gong,et al.  Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathway , 2015, Aging cell.

[42]  D. Cooper,et al.  Loss of exon identity is a common mechanism of human inherited disease. , 2011, Genome research.

[43]  M. Erdal,et al.  Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease? , 2016, Omics : a journal of integrative biology.

[44]  B. Nordestgaard,et al.  Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease , 2015, Alzheimer's & Dementia.

[45]  D. Walsh,et al.  De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. , 2013, Human molecular genetics.

[46]  I. Santana,et al.  MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease , 2015, Alzheimer's & dementia.

[47]  S. Hébert,et al.  Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's Disease , 2015, Molecular therapy. Nucleic acids.

[48]  Hao Wang,et al.  The Anti-dementia Effects of Donepezil Involve miR-206-3p in the Hippocampus and Cortex. , 2017, Biological & pharmaceutical bulletin.

[49]  L. Puglielli,et al.  Withdrawal: Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis , 2003, Journal of Biological Chemistry.

[50]  S. Hébert,et al.  Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function , 2011, Molecular Neurodegeneration.

[51]  L. Mucke,et al.  Paths of Convergence: Sirtuins in Aging and Neurodegeneration , 2008, Neuron.

[52]  Jürgen Götz,et al.  Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β , 2011, Journal of Molecular Neuroscience.

[53]  Peng Liu,et al.  miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation , 2009, Brain Research Bulletin.

[54]  J. Thome,et al.  A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms , 2007, Molecular Psychiatry.

[55]  T. Rana,et al.  Translation Repression in Human Cells by MicroRNA-Induced Gene Silencing Requires RCK/p54 , 2006, PLoS biology.

[56]  B. Pillai,et al.  Regulation of BACE1 by miR-29a/b in a cellular model of Spinocerebellar ataxia 17 , 2012, RNA biology.

[57]  D. Baltimore,et al.  MicroRNAs as regulatory elements in immune system logic , 2016, Nature Reviews Immunology.

[58]  M. Carrillo,et al.  Research priorities to reduce the global burden of dementia by 2025 , 2016, The Lancet Neurology.

[59]  S. Stamm,et al.  Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors , 2004, Journal of neurochemistry.

[60]  V. Caputo,et al.  Brain Derived Neurotrophic Factor (BDNF) Expression Is Regulated by MicroRNAs miR-26a and miR-26b Allele-Specific Binding , 2011, PloS one.

[61]  A. Delacourte,et al.  MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.

[62]  S. Narumiya,et al.  The CCAAT/enhancer-binding protein delta/miR135a/thrombospondin 1 axis mediates PGE2-induced angiogenesis in Alzheimer's disease , 2015, Neurobiology of Aging.

[63]  Fani Sousa,et al.  Recombinant pre-miR-29b for Alzheimer´s disease therapeutics , 2016, Scientific Reports.

[64]  M. Esiri,et al.  Haplotype-specific expression of exon 10 at the human MAPT locus. , 2006, Human molecular genetics.

[65]  Jaekwang Kim,et al.  miR‐186 is decreased in aged brain and suppresses BACE1 expression , 2016, Journal of neurochemistry.